Cited by 165Antifungal resistance and susceptibilityBacterial Identification and Susceptibility TestingInfective Endocarditis Diagnosis and Management

Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel

Clancy, Cornelius J, Pappas, Peter G, Vazquez, Jose, Judson, Marc A, Kontoyiannis, Dimitrios P, Thompson, George R, Garey, Kevin W, Reboli, Annette +8 more·2018·Clinical Infectious Diseases

Abstract

Background: Blood cultures are approximately 50% sensitive for diagnosing invasive candidiasis. The T2Candida nanodiagnostic panel uses T2 magnetic resonance and a dedicated instrument to detect Candida directly within whole blood samples. Methods: Patients with Candida albicans, Candida glabrata, Candida parapsilosis, Candida tropicalis, or Candida krusei candidemia were identified at 14 centers using diagnostic blood cultures (dBCs). Follow-up blood samples were collected concurrently for testing by T2Candida and companion cultures (cBCs). T2Candida results are reported qualitatively for C. albicans/C. tropicalis, C. glabrata/C. krusei, and C. parapsilosis. T2Candida and cBCs were positive if they detected a species present in the dBC. Results: Median time between collection of dBC and T2Candida/cBC samples in 152 patients was 55.5 hours (range, 16.4-148.4). T2Candida and cBCs were positive in 45% (69/152) and 24% (36/152) of patients, respectively (P < .0001). T2Candida clinical sensitivity was 89%, as positive results were obtained in 32/36 patients with positive cBCs. Combined test results were both positive (T2+/cBC+), 21% (32/152); T2+/cBC-, 24% (37/152); T2-/cBC+, 3% (4/152); and T2-/cBC-, 52% (79/152). Prior antifungal therapy, neutropenia, and C. albicans candidemia were independently associated with T2Candida positivity and T2+/cBC- results (P values < .05). Conclusions: T2Candida was sensitive for diagnosing candidemia at the time of positive blood cultures. In patients receiving antifungal therapy, T2Candida identified bloodstream infections that were missed by cBCs. T2Candida may improve care by shortening times to Candida detection and species identification compared to blood cultures, retaining sensitivity during antifungal therapy and rendering active candidemia unlikely if results are negative. Clinical Trials Registration: NCT01525095.

Integrity signals

Registry

Crossref · 10.1093/cid/cix1095

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Patients who had received antifungal treatment were more likely to have negative blood cultures and positive T2Candida results.

    “Patients who had received antifungal treatment were more likely to have negative blood cultures and positive T2Candida results.”

    From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [83]

  • In a multicenter study of patients with candidemia, the sensitivity of T2Candida was double that of conventional blood cultures when both were tested on follow-up blood samples.

    “In a multicenter study of patients with candidemia, the sensitivity of T2Candida was double that of conventional blood cultures when both were tested on follow-up blood samples [83].”

    From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [83]

  • T2Candida represents an important advance as the first commercially available, fully-automated rapid assay that specifically detects Candida species.

    “T2Candida represents an important advance as the first commercially available, fully-automated rapid assay that specifically detects Candida species.”

    From Treatment of Invasive Candidiasis: A Narrative Review (2018) · cites this paper as [83]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Clancy, C. J., Pappas, P. G., Vazquez, J., Judson, M. A., Kontoyiannis, D. P., Thompson, G. R., Garey, K. W., Reboli, A., Greenberg, R. N., Apewokin, S., Lyon, G. M., Ostrosky-Zeichner, L., Wu, A. H. B., Tobin, E., Nguyen, M. H., & Caliendo, A. M.
Affiliations
  • University of Pittsburgh Medical Center (US)
  • University of Alabama at Birmingham Hospital (US)
  • Medical College of Georgia, Augusta University, New York
  • Albany Medical College (US)
  • The University of Texas MD Anderson Cancer Center (US)
  • University of California Davis Medical Center (US)
  • University of Houston (US)
  • Cooper Medical School of Rowan University (US)
  • University of Kentucky (US)
  • University of Arkansas Medical Center (US)
  • Emory Healthcare (US)
  • University of Texas Health Science Center, Houston
  • University of California, San Francisco (US)
  • St Peter's Hospital (US)
  • Brown University (US)
Corresponding author
Clancy, Cornelius J
Venue
Clinical Infectious Diseases
Published
2018-02-09
Volume
66
Issue
11
Pages
1678-1686
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2792762681
Cited by
165
References
39
Citations by year
2026: 8 · 2025: 10 · 2024: 15 · 2023: 18 · 2022: 13 · 2021: 26 · 2020: 27 · 2019: 31 · 2018: 17
FWCI
15.79
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Bacterial Identification and Susceptibility Testing
  • Health Sciences › Medicine › Epidemiology › Infective Endocarditis Diagnosis and Management
Keywords
candidemia, invasive candidiasis, Candida species identification, blood culture sensitivity, antifungal therapy, neutropenia, Candida albicans, Candida tropicalis, Candida glabrata, Candida parapsilosis, Candida krusei, rapid fungal detection, diagnostic sensitivity
MeSH terms
Candida, Female, Humans, Male, Middle Aged, Magnetic Resonance Spectroscopy, Prospective Studies, Sensitivity and Specificity, Serologic Tests, Candidemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review